Cubebio announces business combination agreement with mountain crest v to become publicly listed

New york, usa and seoul, korea, aug. 29, 2024 (globe newswire) -- mountain crest acquisition corp. v, a delaware corporation formed as a special purpose acquisition company (“mountain crest v”), with its common stock publicly traded on the nasdaq stock market under the trading symbol “mcag” and cubebio co., ltd., a corporation (“chusik hoesa”) organized under the laws of korea (“cubebio”), which has an innovative technology that diagnoses cancer at an early stage using urine, today announced that the parties entered into a definitive business combination agreement, dated august 29, 2024 (the “bca”) for a proposed business combination transaction through which cubebio plans to become a public company with its securities listed on the nasdaq stock market. mountain crest v is the fifth vehicle in the mountain crest family of spacs, the management of which has successfully completed four prior spac business combinations.
NDAQ Ratings Summary
NDAQ Quant Ranking